The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Weyer Christian since 2010.
The trader's CIK number is 1493811.
At the time of the last reporting, Weyer Christian was the SVP, Research & Development of Intercept Pharmaceuticals, Inc.. (stock ticker symbol ICPT).
Also see all insider trading activities at Intercept Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | ICPT | 0 | $0 | 1,017 | $93,447 | 0 | $0 |
| 2019 | ICPT | 0 | $0 | 11,678 | $1,169,870 | 7,625 | $449,340 |
| 2018 | ICPT | 0 | $0 | 1,343 | $152,806 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | FATE | 0 | $0 | 0 | $0 | 25,000 | $34,250 |
| 2014 | FATE | 0 | $0 | 10,000 | $90,183 | 10,000 | $13,699 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | AMLN | 0 | $0 | 7,593 | $127,811 | 0 | $0 |
| 2010 | AMLN | 0 | $0 | 1,314 | $17,633 | 0 | $0 |
1. Intercept Pharmaceuticals, Inc. (ICPT)
2. Fate Therapeutics Inc (FATE)
3. Amylin Pharmaceuticals Inc (AMLN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-04-27 | ICPT | Sale | 181 | 85.95 | 15,556 |
| 2020-02-27 | ICPT | Sale | 113 | 87.62 | 9,901 |
| 2020-01-27 | ICPT | Sale | 723 | 94.04 | 67,990 |
| 2019-12-27 | ICPT | Option Ex | 470 | 58.93 | 27,697 |
| 2019-12-27 | ICPT | Sale | 1,581 | 123.24 | 194,842 |
| 2019-11-27 | ICPT | Sale | 1,040 | 101.65 | 105,716 |
| 2019-11-27 | ICPT | Option Ex | 927 | 58.93 | 54,628 |
| 2019-11-25 | ICPT | Sale | 1,855 | 100.00 | 185,500 |
| 2019-11-26 | ICPT | Sale | 4,373 | 100.00 | 437,300 |
| 2019-11-25 | ICPT | Option Ex | 1,855 | 58.93 | 109,315 |
| 2019-11-26 | ICPT | Option Ex | 4,373 | 58.93 | 257,700 |
| 2019-11-19 | ICPT | Sale | 1,550 | 85.00 | 131,750 |
| 2019-11-13 | ICPT | Sale | 946 | 85.00 | 80,410 |
| 2019-03-01 | ICPT | Sale | 333 | 103.16 | 34,352 |
| 2018-11-29 | ICPT | Sale | 1,343 | 113.78 | 152,806 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-04-13 | FATE | Option Ex | 25,000 | 1.37 | 34,250 |
| 2014-04-02 | FATE | Sale | 2,262 | 9.02 | 20,394 |
| 2014-04-01 | FATE | Sale | 7,738 | 9.02 | 69,789 |
| 2014-04-02 | FATE | Option Ex | 2,262 | 1.37 | 3,098 |
| 2014-04-01 | FATE | Option Ex | 7,738 | 1.37 | 10,601 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-03-01 | AMLN | Sale | 1,231 | 17.11 | 21,062 |
| 2012-02-23 | AMLN | Sale | 2,519 | 17.03 | 42,898 |
| 2012-02-08 | AMLN | Sale | 3,843 | 16.61 | 63,851 |
| 2010-11-19 | AMLN | Sale | 1,314 | 13.42 | 17,633 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Weyer Christian (SVP, Research & Development of Intercept Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.